Systems, devices, and methods for treating a pulmonary disorder with an agent
Inventors
Mayse, Martin L. • Mertens, Steven P.
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
A medication delivery device for treatment of a pulmonary disorder in a patient includes an elongate member, an expandable member is coupled to a distal end of the elongate member, and an agent delivery portion coupled to an external surface of the expandable member. The agent delivery portion includes an agent that disrupts nerve activity.
Core Innovation
The invention provides methods for delivering an agent to an airway of a patient to treat a pulmonary disorder. An expandable member carries a medication delivery portion positioned entirely between adjacent cartilage rings to contact the airway wall. The delivered agent transfers into the airway wall to affect nerves running along the airway and relieve airway obstruction in at least one distal airway.
The medication delivery portion protrudes from adjacent surfaces of the expandable member and extends at least partially circumferentially about the member. One configuration specifies ribosome-inactivating proteins as the agent with adjacent marker elements, while another specifies a tethered ring coated with a nerve-disrupting agent. The agent transfers directly into the airway wall to affect airway nerves.
Claims Coverage
The provided claims identify two independent claims, covering two inventive features for delivering an agent to an airway using an expandable member.
Airway delivery of ribosome-inactivating proteins
Claim 1 covers positioning an expandable member such that a medication delivery portion, with marker elements immediately adjacent on proximal and distal sides, contacts an airway wall entirely between adjacent cartilage rings. The delivery portion protrudes from adjacent surfaces of the expandable member and transfers ribosome-inactivating proteins into the wall to affect airway nerves and relieve distal airway obstruction.
Airway delivery from a tethered medication ring
Claim 22 covers an expandable member carrying a medication delivery portion comprising a tethered ring coated with a nerve-disrupting agent. The ring protrudes from adjacent surfaces of the expandable member and contacts the airway wall entirely between adjacent cartilage rings, transferring the agent into the wall to affect airway nerves and relieve distal airway obstruction.
The independent claims cover delivering an agent into the airway wall between adjacent cartilage rings using an expandable member, specifying either ribosome-inactivating proteins or a tethered ring carrying a nerve-disrupting agent to relieve distal airway obstruction.
Stated Advantages
The transferred agent affects nerves running along the airway to relieve airway obstruction in at least one airway distal to the treatment location.
Documented Applications
Delivering an agent or medication to an airway of a patient to treat a pulmonary disorder and relieve distal airway obstruction.
Interested in licensing this patent?